MassIVE MSV000092698

Partial Public

SRM PFAS NTA Data Agilent Revident Q-TOF: Expanding PFAS Coverage in Non-Targeted Analysis Using Data-Independent Analysis and IonDecon with FluoroMatch Suite

Description

non-targeted analysis PFAS data acquired on the state-of-the-art Revident LC Q-TOF for estuarine sediment (BCR667), sewage sludge (ERMCC144), dried sediment from Milwaukee Bay, WI, USA (SRM1936), freeze-dried sediment (SRM1941b), human plasma (SRM1950), organic contaminants in house dust (SRM2585), and domestic sludge (SRM 2781). For SRM 2781 the data goes alongside a manuscript describing the following: All Ions with deconvolution using IonDecon is a complementary approach to use with DDA or intelligent acquisition methods. All Ions improves coverage in complex matrices by providing fragmentation for every feature where fragments can be correlated with precursor ions. It provides coverage of low abundance intensity ions not selected by DDA. Furthermore, it provides isotopic ratios in the fragmentation spectra, which can be used for aiding characterization of unknowns. While IonDecon and All Ions can reduce false negatives, it was also shown to increase false positives, and therefore some issues of All Ions should be understood by the user and accounted for when annotating using All Ions. These include retaining fragments which do not belong to precursor ions, but rather belong to other adducts, dimers, and other correlating compounds. Furthermore, fragment ions may be retained due to false positives, thousands of MS/MS peaks are often included in All Ions spectra, and hence the random chance for a fragment to correlate with a precursor is high. To obtain better spectral quality, more stringent thresholds can be used but these will also increase false negatives. IonDecon also can be used for QRAI data, which may further reduce these issues and can be used in any workflow which requires MS/MS files. As part of an overall workflow, All Ions and IonDecon will improve MS/MS coverage of PFAS molecules. IonDecon will aid in discovering more PFAS present in the environment which will enable the associated health burden to be investigated. This understanding can be used for developing regulations and mitigation strategies for legacy PFAS as well as newly discovered PFAS. [doi:10.25345/C58912193] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: PFAS ; NTA ; FluoroMatch ; SRM ; House Dust ; Sewage ; Domestic Sewage ; estuarine sediment ; sewage sludge ; dried sediment ; freeze-dried sediment ; human plasma ; organic contaminants in house dust ; domestic sludge

Contact

Principal Investigators:
(in alphabetical order)
Jeremy Koelmel, Innovative Omics Inc, United States
John A. Bowden, University of Florida, United States
Krystal G. Pollitt, Yale University, United States
Olivier Chevallier, Agilent Technologies, Unites States
Submitting User: jeremykoelmel
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.